The updated capabilities of SwiftMR include personalized scan settings within the software, artifact reduction and cloud integration.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Study: Adjunctive AI Provides Over 18 Percent Higher Lesion-Level Sensitivity on Prostate MRI
Emerging research revealed significantly enhanced sensitivity for prostate cancer detection with adjunctive and stand-alone use of AI.
-
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
-
Diagnostic Imaging's Weekly Scan: July 6 — July 12
Stay updated with the latest in radiology, including PET, MRI, and AI research, plus essential insights on mammography and cardiac imaging.
-
CCTA Study: Plaque Burden Offers No Prognostic Benefit for Predicting Cardiac Events in Patients with Acute Chest Pain
For patients who had coronary CTA for acute chest pain, emerging research found no significant association between plaque burden grades with CAD-RADS 2.0 and cardiac events.
-
Can AI Enhance Ultrasound Detection of Cardiac Amyloidosis? What a Multicenter Study Reveals
EchoGo Amyloidosis, an echocardiography-based AI screening software, demonstrated a 93 percent AUROC for cardiac amyloidosis detection in a new multicenter study.
-
Study: Photon-Counting CT Reduces Radiation Dosing by More than 40 Percent in Kids with Congenital Heart Disease
For pediatric patients with congenital heart disease, new research showed that cardiac PCCT yielded comparable signal-to-noise and contrast-to-noise ratios to energy-integrating detector CT at over a 43 percent lower dose length product.
-
Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy
Currently in a phase I trial for solid prostate cancer tumors, the deoxycytidine kinase inhibitor TRE-515 garnered the fast track designation for possible combination use with Pluvicto in treating mCRPC.
-
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.